Insider Purchase by Column Group IV GP, LP (10% Owner)

1 Month
After Trade
Before Trade

Trade Summary

1 week ago, Column Group IV GP, LP, serving as 10% owner Owner at Eikon Therapeutics, Inc. (EIKN), purchased 89,200 shares at $11.56 per share, for a total transaction value of $1,031,044.96. Following this transaction, Column Group IV GP, LP now holds 89,200 shares of EIKN.

The trade was executed on Thursday, September 3, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, September 8, 2026 at 4:33 PM ET, 5 days after the trade was made.

Eikon Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

Trade Price

$11.56

Quantity

89,200

Total Value

$1,031,044.96

Shares Owned

89,200

Trade Date

7 days ago

SEC Filing Date

at 4:33 PM ET

Filed 5 days after trade

HEALTHCAREBIOTECHNOLOGY

Discussion

Sign in to join the discussion.
View news mentioning EIKN